Forbes
September 3, 2025
Forbes
September 3, 2025
Forbes covered XPANCEO and INTRA-KER’s joint breakthrough — an intracorneal implant designed to restore vision in patients with corneal blindness tested in a human eye.
The piece highlights how the device projects images directly onto the retina, bypassing the cornea, and describes the innovation as “a paradigm shift away from biology to engineered solutions that focus on information delivery”.
Read the full article on Forbes.